About Dapagliflozin Sitagliptin And Metformin hydrochloride Tablets
Dapagliflozin Sitagliptin And Metformin hydrochloride Tablets are a top-tier combination therapy designed for adults with type 2 diabetes mellitus unresponsive to monotherapy. These scarce yet excellent film-coated, oval tablets are available in white to off-white color and deliver redoubtable efficacy. Highly favorable reviews underscore their effectiveness. Each tablet seamlessly blends 10 mg Dapagliflozin, 100 mg Sitagliptin, and 500/1000 mg Metformin Hydrochloride, delivering potent results through oral administration. Marketed by leading Indian pharmaceutical suppliers, these prescription medicines require careful physician guidance, especially for those with renal or hepatic impairment. Explore optimal diabetes management with this advanced antidiabetic therapy.
Outstanding Features and Applications
The surface of application for these antidiabetic tablets is strictly oral, and their film-coated design ensures easy swallowing and minimal taste disruption. Among the special features are secure blister strip packaging and a range of dosage strengths tailored for individual requirements. Their primary competitive advantage lies in the synergistic combination of three proven agents, achieving excellent glycemic control where monotherapy falls short. Rigorous manufacturing standards in India further enhance their redoubtable safety profile.
Sample Availability, Certification, and Logistics
Samples of Dapagliflozin Sitagliptin And Metformin hydrochloride Tablets are available for evaluation by healthcare professionals and suppliers. Deliveries are facilitated through reliable logistics partners to ensure prompt and secure arrival. The product holds the required Indian regulatory certifications, confirming its approval and quality. With strong supply ability, traders and suppliers can efficiently deliver varied packaging quantities, ensuring constant availability across markets. Packaging is commonly delivered as 5 x 10 tablet blister boxes, streamlining inventory management.
FAQ's of Dapagliflozin Sitagliptin And Metformin hydrochloride Tablets:
Q: How should I take Dapagliflozin Sitagliptin And Metformin hydrochloride Tablets for optimal results?
A: These tablets should be taken orally with or after meals as per your doctor's prescription. Always follow your healthcare provider's dosage instructions closely.
Q: What are the main benefits of using this antidiabetic combination therapy?
A: This medication offers excellent glycemic control for adults with type 2 diabetes mellitus unresponsive to monotherapy, thanks to its synergistic blend of dapagliflozin, sitagliptin, and metformin hydrochloride.
Q: When is Dapagliflozin Sitagliptin And Metformin hydrochloride Tablets contraindicated?
A: This medicine is not recommended for patients with renal impairment, hypersensitivity to any of its components, or in certain hepatic conditions. Always consult your physician before use.
Q: Where are these tablets manufactured and marketed?
A: These tablets are manufactured and marketed by various reputable Indian pharmaceutical companies, following stringent quality and safety standards.
Q: What side effects should I look out for during usage?
A: Possible side effects may include hypoglycemia, urinary tract infections, and gastrointestinal discomfort. If you experience persistent or severe symptoms, contact your healthcare provider promptly.
Q: How are these tablets packaged for delivery and supply?
A: The tablets are usually supplied in blister strips, commonly in quantities of 10 or 14 tablets per strip and packaged as 5 x 10 tablets per box, ensuring secure and convenient handling during delivery and storage.